Premium
Recurrent coronary disease in HIV ‐infected patients: role of drug–drug interactions
Author(s) -
Bravo Iria,
Álvarez Hortensia,
Mariño Ana,
Clotet Bonaventura,
Moltó José
Publication year - 2018
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.13583
Subject(s) - medicine , drug , coronary artery disease , acute coronary syndrome , comorbidity , human immunodeficiency virus (hiv) , disease , revascularization , immunology , pharmacology , myocardial infarction
Cardiovascular disease represents a leading comorbidity in HIV populations. Different factors may contribute to the recurrence of cardiovascular events in HIV‐infected patients. Here, we describe two patients with HIV infection and an acute coronary syndrome who developed in‐stent thrombosis after a percutaneous revascularization procedure. Also, we discuss the potential role of drug interactions between antiretroviral and antiplatelet treatments as a contributing factor for recurrent coronary disease in HIV‐infected patients.